Deborah Castelletti

927 total citations
6 papers, 136 citations indexed

About

Deborah Castelletti is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Deborah Castelletti has authored 6 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Deborah Castelletti's work include Glioma Diagnosis and Treatment (2 papers), Chromatin Remodeling and Cancer (2 papers) and interferon and immune responses (1 paper). Deborah Castelletti is often cited by papers focused on Glioma Diagnosis and Treatment (2 papers), Chromatin Remodeling and Cancer (2 papers) and interferon and immune responses (1 paper). Deborah Castelletti collaborates with scholars based in Switzerland, United States and Germany. Deborah Castelletti's co-authors include Alexandre Arcaro, Michael A. Grotzer, Giulio Fiaschetti, Tarek Shalaby, Christina I. Schroeder, Frank Westermann, Kazuo Nagasawa, Ilian Jelesarov, Kazuo Shin‐ya and Masayuki Tera and has published in prestigious journals such as Oncogene, Scientific Reports and Molecular Cancer Therapeutics.

In The Last Decade

Deborah Castelletti

6 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Castelletti Switzerland 6 117 21 20 18 15 6 136
Giulia Sdruscia Italy 4 141 1.2× 19 0.9× 16 0.8× 15 0.8× 19 1.3× 6 154
Laura Benedetta Amato Italy 7 110 0.9× 18 0.9× 61 3.0× 21 1.2× 10 0.7× 10 149
Susanne Gröbner Germany 4 66 0.6× 20 1.0× 26 1.3× 10 0.6× 38 2.5× 4 99
E.M.S.F. Ribeiro Brazil 7 90 0.8× 44 2.1× 39 1.9× 22 1.2× 11 0.7× 12 145
Oihane Erice Spain 5 57 0.5× 35 1.7× 15 0.8× 25 1.4× 15 1.0× 7 110
Heather A. Ely United States 4 80 0.7× 39 1.9× 23 1.1× 32 1.8× 9 0.6× 6 172
Émilie Indersie France 7 89 0.8× 14 0.7× 47 2.4× 7 0.4× 15 1.0× 18 147
Françoise Bonnet‐Dorion Italy 2 101 0.9× 30 1.4× 31 1.6× 26 1.4× 7 0.5× 2 132
Fanying Tang United States 4 73 0.6× 36 1.7× 22 1.1× 9 0.5× 5 0.3× 5 107
Ujunwa Cynthia Okoye-Okafor United States 4 119 1.0× 19 0.9× 16 0.8× 10 0.6× 9 0.6× 5 176

Countries citing papers authored by Deborah Castelletti

Since Specialization
Citations

This map shows the geographic impact of Deborah Castelletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Castelletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Castelletti more than expected).

Fields of papers citing papers by Deborah Castelletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Castelletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Castelletti. The network helps show where Deborah Castelletti may publish in the future.

Co-authorship network of co-authors of Deborah Castelletti

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Castelletti. A scholar is included among the top collaborators of Deborah Castelletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Castelletti. Deborah Castelletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Liu, Yang, Martin Pejchinοvski, Xueqi Wang, et al.. (2018). Dual mTOR/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease. Scientific Reports. 8(1). 5584–5584. 23 indexed citations
2.
Fiaschetti, Giulio, Christina I. Schroeder, Deborah Castelletti, et al.. (2014). NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathologica Communications. 2(1). 39–39. 30 indexed citations
3.
Fiaschetti, Giulio, Deborah Castelletti, Stefan Zoller, et al.. (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene. 30(25). 2823–2835. 21 indexed citations
4.
Shalaby, Tarek, André O. von Bueren, Giulio Fiaschetti, et al.. (2010). Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD. Molecular Cancer Therapeutics. 9(1). 167–179. 39 indexed citations
5.
Castelletti, Deborah, Giulio Fiaschetti, Valeria Di Dato, et al.. (2010). The Quassinoid Derivative NBT-272 Targets Both the AKT and ERK Signaling Pathways in Embryonal Tumors. Molecular Cancer Therapeutics. 9(12). 3145–3157. 11 indexed citations
6.
Grotzer, Michael A., Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby, & Alexandre Arcaro. (2009). Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System. Current Cancer Drug Targets. 9(2). 176–188. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026